BlackRock Inc. Invests $2.80 Million in Akero Therapeutics (NASDAQ:AKRO)
BlackRock Inc. purchased a new position in shares of Akero Therapeutics (NASDAQ:AKRO) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 146,162 shares of the company’s stock, valued at approximately $2,798,000. BlackRock Inc. owned approximately 0.54% of Akero Therapeutics at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of AKRO. Tiverton Asset Management LLC bought a new position in shares of Akero Therapeutics in the second quarter valued at about $54,000. SG Americas Securities LLC bought a new stake in Akero Therapeutics during the 2nd quarter worth about $192,000. Northern Trust Corp bought a new ...